Darlene B. Royce

2.1k total citations
39 papers, 1.7k citations indexed

About

Darlene B. Royce is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Darlene B. Royce has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Darlene B. Royce's work include Genomics, phytochemicals, and oxidative stress (12 papers), Multiple Sclerosis Research Studies (6 papers) and Estrogen and related hormone effects (6 papers). Darlene B. Royce is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (12 papers), Multiple Sclerosis Research Studies (6 papers) and Estrogen and related hormone effects (6 papers). Darlene B. Royce collaborates with scholars based in United States, United Kingdom and Italy. Darlene B. Royce's co-authors include Karen T. Liby, Michael B. Sporn, Charlotte R. Williams, Renee Risingsong, Gordon W. Gribble, Tadashi Honda, Mark M. Yore, Nanjoo Suh, Francesca Gilli and Andrew R. Pachner and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Darlene B. Royce

39 papers receiving 1.7k citations

Peers

Countries citing papers authored by Darlene B. Royce

Since Specialization

Citations

This map shows the geographic impact of Darlene B. Royce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darlene B. Royce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darlene B. Royce more than expected).

Fields of papers citing papers by Darlene B. Royce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darlene B. Royce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darlene B. Royce. The network helps show where Darlene B. Royce may publish in the future.

Co-authorship network of co-authors of Darlene B. Royce

This figure shows the co-authorship network connecting the top 25 collaborators of Darlene B. Royce. A scholar is included among the top collaborators of Darlene B. Royce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darlene B. Royce. Darlene B. Royce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Community composition and the environment modulate the population dynamics of type VI secretion in human gut bacteria 2023 ·Nature Ecology & Evolution ·(unknown), (unknown), Adrian J. Verster, (unknown), Darlene B. Royce, (unknown), (unknown), Daniel Schultz, Carey D. Nadell, Benjamin D. Ross	18
2	Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis 2019 ·Journal of Neuroinflammation ·Krista D. DiSano, (unknown), Darlene B. Royce, Andrew R. Pachner, Francesca Gilli	17
3	Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis 2019 ·Frontiers in Immunology ·Krista D. DiSano, Darlene B. Royce, Francesca Gilli, Andrew R. Pachner	25
4	Quantitative Measurement of Intrathecally Synthesized Proteins in Mice 2019 ·Journal of Visualized Experiments ·Francesca Gilli, (unknown), (unknown), Darlene B. Royce, Krista D. DiSano, Andrew R. Pachner	1
5	Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta 2018 ·International Immunopharmacology ·Francesca Gilli, (unknown), Darlene B. Royce, Andrew R. Pachner	3
6	Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide 2017 ·Journal of NeuroVirology ·Francesca Gilli, Libin Li, Darlene B. Royce, Krista D. DiSano, Andrew R. Pachner	17
7	Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis 2017 ·Journal of Neuroimmunology ·Francesca Gilli, Darlene B. Royce, Krista D. DiSano, Andrew R. Pachner	4
8	Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer 2017 ·Cancer Letters ·Ana S. Leal, Charlotte R. Williams, Darlene B. Royce, Patricia A. Pioli, Michael B. Sporn, Karen T. Liby	96
9	Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer 2017 ·Theranostics ·(unknown), Rajiv Kumar, Paige Baldwin, (unknown), Ana S. Leal, Darlene B. Royce, Di Zhang, Anne L. van de Ven, Karen T. Liby, Srinivas Sridhar	26
10	Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis 2016 ·Journal of Visualized Experiments ·Francesca Gilli, Darlene B. Royce, Andrew R. Pachner	16
11	The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice 2015 ·Cancer Prevention Research ·(unknown), Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Michael B. Sporn, Karen T. Liby	19
12	Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis 2015 ·Carcinogenesis ·Ciric To, Carol S. Ringelberg, Darlene B. Royce, Charlotte R. Williams, Renee Risingsong, Michael B. Sporn, Karen T. Liby	60
13	Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention 2015 ·Pharmacological Research ·(unknown), (unknown), Charlotte R. Williams, Darlene B. Royce, Gordon W. Gribble, Michael B. Sporn, Karen T. Liby	26
14	The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor–Negative Mammary Carcinogenesis in Polyoma Middle T Mice 2012 ·Cancer Prevention Research ·Kim‐Vy Tran, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Michael B. Sporn, Karen T. Liby	40
15	The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer 2012 ·Carcinogenesis ·(unknown), Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Michael B. Sporn, Patricia A. Pioli, Lalji K. Gediya, Vincent C.O. Njar, Karen T. Liby	40
16	Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer 2010 ·Cancer Prevention Research ·Karen T. Liby, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Anirban Maitra, Ralph H. Hruban, Michael B. Sporn	78
17	Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 2008 ·Clinical Cancer Research ·Karen T. Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Mark M. Yore, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Nicola Vannini, Ilaria Sogno, Adriana Albini, Michael B. Sporn	66
18	The triterpenoid, CDDO-methyl ester, and the rexinoid, LG100268, synergize in the prevention of mammary tumors in a mouse model of estrogen receptor-negative breast cancer. 2006 ·Cancer Epidemiology and Prevention Biomarkers ·Karen T. Liby, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Michael B. Sporn	1
19	Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A 2006 ·Bioorganic & Medicinal Chemistry Letters ·Tadashi Honda, Karen T. Liby, (unknown), Chitra Sundararajan, Yukiko Honda, Nanjoo Suh, Renee Risingsong, Charlotte R. Williams, Darlene B. Royce, Michael B. Sporn, Gordon W. Gribble	40
20	The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling 2005 ·Cancer Research ·Karen T. Liby, Thomas Hock, Mark M. Yore, Nanjoo Suh, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Darlene B. Royce, Tadashi Honda, Yukiko Honda, Gordon W. Gribble, Nathalie Hill‐Kapturczak, Anupam Agarwal, Michael B. Sporn	239

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact